All News

The risks of incontinence and sexual dysfunction are high after both robot-assisted laparoscopic radical prostatectomy and open radical prostatectomy among Medicare-age men, results of a recent multicenter study show.

Results from testing in an initial patient cohort indicate the potential for a six-gene, whole blood RNA-based expression panel to predict survival in men with progressive metastatic castration-resistant prostate cancer.

Post-radical prostatectomy erectile function recovery is much lower than physician-reported rates, a study indicates.

The advent of nerve-sparing radical prostatectomy and its outcomes has focused attention on the etiology of erectile dysfunction following all forms of prostate cancer intervention.

During periods of dramatic market fluctuation, it is important for investors to avoid emotional responses to investing.

There is a lot we can do to improve our practices' efficiency and productivity. One of the simplest methods is to decrease the no-show rate, a problem that affects most medical practices.

Peter R. Carroll, MD, MPH, discusses the positive and negative aspects of the U.S. Preventive Services Task Force prostate cancer screening recommendation and provides a unique perspective on how the urology community should respond.

Pain interference with daily functioning was significantly less in men with castrate-resistant prostate cancer who were treated with the RANK ligand inhibitor denosumab (XGEVA) compared to zoledronic acid (Zometa) as part of a multinational, double-blind, randomized trial.

Urologists and other physicians across the country now find themselves in the midst of a high stakes game of "chicken" on Capitol Hill, with their level of compensation for treating Medicare patients at stake.

A new AUA standard operating practice document aims to help with robotic surgery credentialing for practicing urologists and those in training.

Whether a coverage arrangement is in place makes all the difference when seeing another urologist's patients.

Results of in vitro studies indicate that E-twenty six (ETS) gene fusions in prostate cancer may be a biomarker of radiation resistance and a potential target for reversing radioresistance through treatment with a poly(ADP-ribose)polymerase 1 (PARP1) inhibitor.

A composite score calculated from a 46-gene RNA signature independently predicts cancer death among men with clinically localized prostate cancer managed by active surveillance.

Hiring a friend is usually not a good idea, because it can cause more problems in your practice than it solves.

Almost half of prostate cancer deaths occur among men with PSA levels in the top 10% when assessed at age 44 to 50 years. This small group could benefit from intense surveillance over the ensuing years, whereas in about half of men, three lifetime PSA tests appear sufficient to capture the risk of prostate cancer metastases or death 10 or more years in advance.

Among men treated with curative radiation therapy and neoadjuvant, adjuvant, or concurrent androgen deprivation therapy (ADT), about one-fourth fail to achieve or maintain true castrate levels of testosterone suppression.

Men with lower urinary tract symptoms (LUTS) associated with large prostates had significantly greater improvement in functional outcomes when treated with holmium laser enucleation of the prostate (HoLEP) than with photoselective vaporization of the prostate (PVP).

Surveys of patients and their partners have found previous numbers regarding post-op potency to be highly unrealistic, and results of recent studies, such as one from Memorial Sloan-Kettering Cancer Center, are closer to reality.

Researchers found that stretched penile length following radical prostatectomy for prostate cancer decreased until 36 months post-op, then at this point, the process appears to reach a nadir and reverse itself so that by 48 months, stretched length appeared to be fully restored at 5 years post-op.

An experimental treatment for urinary tract infections has passed its first test in animals, alleviating weeks-long infections in mice in as little as 6 hours, according to a recent study.

Female stress urinary incontinence treatment with single-incision mini-slings yields significantly lower cure rates and higher risk of repeat surgery compared with standard midurethral slings.

If you are serious about going green, get your staff involved. Start with conducting an environment audit of what products you use, how they are discarded, and where there may be unnecessary waste.

Staring down a possible 27% reimbursement cut, questions about the viability of health care reform, increasing demand for their services, and a shrinking work force, it's less than surprising that urologists are anxious about the prospects for their profession.

Urologists generally use the recommendation as the basis of a frank discussion with patients.

Even if they didn't do well in the stock market, many focus on their health and enjoy their work.

Kenneth M. Peters, MD, discusses the various forms of neurostimulation, current research efforts, and potential future uses for this modality.

Urologists and other health care providers now need to consider whether to participate in the federal government's new accountable care organization program, finalized in mid-October as a way to help reduce Medicare costs while improving patient care.